Shaking is far too aggressive and will absolutely denature the peptide
Moots RJ, Curiale C, Petersel D, Rolland C, Jones H, Mysler E
You qualify for GLP-1 medications under FDA labeling without any additional conditions
The incidence is typically highest during the initial weeks of treatment and during dose escalation periods
You should contact your GP if: You are experiencing intolerable side effects that affect your quality of life or daily functioning You have achieved your target weight and wish to discuss maintenance strategies You are planning pregnancy (semaglutide should be discontinued at least 2 months before planned conception
Options your provider may consider include extending the time between dose increases to give your gut more time to adapt, temporarily reducing the dose until constipation management strategies take effect, or switching between GLP-1 medications if one produces intolerable side effects